Do analysts recommend ADCT or GRML?

ADC Therapeutics presently has a consensus price target of $6.25, indicating a potential upside of 492.98%. Given ADC Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe ADC Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ADC Therapeutics 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer ADCT or GRML?

In the previous week, ADC Therapeutics and ADC Therapeutics both had 2 articles in the media. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.93 beat ADC Therapeutics' score of -0.67 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ADC Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CNTX or GRML?

Context Therapeutics presently has a consensus price target of $6.60, indicating a potential upside of 374.82%. Given Context Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Context Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Context Therapeutics 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.88 Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, CNTX or GRML?

Context Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Context Therapeutics N/A N/A -$36.12M -$0.42 N/A Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A

Is CNTX or GRML more profitable?

Context Therapeutics' return on equity of -59.95% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Context Therapeutics N/A -59.95% -54.78% Greenland Mines Ltd. Common Stock N/A -109.40% -98.80%

Does the media prefer CNTX or GRML?

In the previous week, Context Therapeutics had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Context Therapeutics and 2 mentions for Greenland Mines Ltd. Common Stock. Context Therapeutics' average media sentiment score of 0.93 equaled Greenland Mines Ltd. Common Stock'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Context Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate GRML or NRXP?

NRx Pharmaceuticals has a consensus price target of $38.25, indicating a potential upside of 896.09%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe NRx Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NRx Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Is GRML or NRXP more profitable?

NRx Pharmaceuticals' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% NRx Pharmaceuticals N/A N/A -202.92%

Does the media refer more to GRML or NRXP?

In the previous week, Greenland Mines Ltd. Common Stock and Greenland Mines Ltd. Common Stock both had 2 articles in the media. NRx Pharmaceuticals' average media sentiment score of 1.20 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that NRx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NRx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate GRML or SPRB?

Spruce Biosciences has a consensus target price of $169.67, suggesting a potential upside of 226.97%. Given Spruce Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Spruce Biosciences is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Spruce Biosciences 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.56

Is GRML or SPRB more profitable?

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Spruce Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Spruce Biosciences N/A -155.40% -101.67%

Does the media refer more to GRML or SPRB?

In the previous week, Spruce Biosciences had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Spruce Biosciences and 2 mentions for Greenland Mines Ltd. Common Stock. Spruce Biosciences' average media sentiment score of 0.96 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that Spruce Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spruce Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate GRML or CNTB?

Connect Biopharma has a consensus target price of $7.20, suggesting a potential upside of 239.62%. Given Connect Biopharma's stronger consensus rating and higher probable upside, analysts clearly believe Connect Biopharma is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Connect Biopharma 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86

Is GRML or CNTB more profitable?

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Connect Biopharma's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Connect Biopharma N/A -122.29% -97.07%

Greenland Mines Ltd. Common Stock (GRML) Competitors

$0.29 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

GRML vs. ADCT, CNTX, NRXP, SPRB, and CNTB

Should you buy Greenland Mines Ltd. Common Stock stock or one of its competitors? MarketBeat compares Greenland Mines Ltd. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Greenland Mines Ltd. Common Stock include ADC Therapeutics (ADCT), Context Therapeutics (CNTX), NRx Pharmaceuticals (NRXP), Spruce Biosciences (SPRB), and Connect Biopharma (CNTB). These companies are all part of the "pharmaceutical products" industry.

How does Greenland Mines Ltd. Common Stock compare to ADC Therapeutics?

ADC Therapeutics (NYSE:ADCT) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

ADC Therapeutics has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 6.94, indicating that its stock price is 594% more volatile than the broader market.

ADC Therapeutics presently has a consensus price target of $6.25, indicating a potential upside of 492.98%. Given ADC Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe ADC Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADC Therapeutics	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to ADC Therapeutics' net margin of -173.02%. ADC Therapeutics' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ADC Therapeutics	-173.02%	N/A	-44.70%
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%

In the previous week, ADC Therapeutics and ADC Therapeutics both had 2 articles in the media. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.93 beat ADC Therapeutics' score of -0.67 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ADC Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

41.1% of ADC Therapeutics shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 5.4% of ADC Therapeutics shares are held by insiders. Comparatively, 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Greenland Mines Ltd. Common Stock has lower revenue, but higher earnings than ADC Therapeutics. ADC Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADC Therapeutics	$81.36M	1.65	-$142.62M	-$1.05	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Summary

ADC Therapeutics and Greenland Mines Ltd. Common Stock tied by winning 7 of the 14 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Context Therapeutics?

Context Therapeutics (NASDAQ:CNTX) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

Context Therapeutics has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 6.94, indicating that its stock price is 594% more volatile than the broader market.

Context Therapeutics presently has a consensus price target of $6.60, indicating a potential upside of 374.82%. Given Context Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Context Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Context Therapeutics	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.88
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Context Therapeutics' return on equity of -59.95% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Context Therapeutics	N/A	-59.95%	-54.78%
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%

In the previous week, Context Therapeutics had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Context Therapeutics and 2 mentions for Greenland Mines Ltd. Common Stock. Context Therapeutics' average media sentiment score of 0.93 equaled Greenland Mines Ltd. Common Stock'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Context Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

14.0% of Context Therapeutics shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 4.8% of Context Therapeutics shares are held by insiders. Comparatively, 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Context Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Context Therapeutics	N/A	N/A	-$36.12M	-$0.42	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Summary

Context Therapeutics beats Greenland Mines Ltd. Common Stock on 7 of the 13 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to NRx Pharmaceuticals?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and NRx Pharmaceuticals (NASDAQ:NRXP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

In the previous week, Greenland Mines Ltd. Common Stock and Greenland Mines Ltd. Common Stock both had 2 articles in the media. NRx Pharmaceuticals' average media sentiment score of 1.20 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that NRx Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NRx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NRx Pharmaceuticals' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
NRx Pharmaceuticals	N/A	N/A	-202.92%

NRx Pharmaceuticals has a consensus price target of $38.25, indicating a potential upside of 896.09%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe NRx Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NRx Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 4.3% of NRx Pharmaceuticals shares are owned by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are owned by company insiders. Comparatively, 6.4% of NRx Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than NRx Pharmaceuticals. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
NRx Pharmaceuticals	$1.23M	113.11	-$28.62M	-$1.09	N/A

Greenland Mines Ltd. Common Stock has a beta of 6.94, indicating that its share price is 594% more volatile than the broader market. Comparatively, NRx Pharmaceuticals has a beta of 2.14, indicating that its share price is 114% more volatile than the broader market.

Summary

Greenland Mines Ltd. Common Stock beats NRx Pharmaceuticals on 7 of the 13 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Spruce Biosciences?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Spruce Biosciences (NASDAQ:SPRB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Spruce Biosciences has a consensus target price of $169.67, suggesting a potential upside of 226.97%. Given Spruce Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Spruce Biosciences is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Spruce Biosciences	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Spruce Biosciences. Spruce Biosciences is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Spruce Biosciences	$4.91M	29.06	-$38.97M	-$36.60	N/A

Greenland Mines Ltd. Common Stock has a beta of 6.94, indicating that its share price is 594% more volatile than the broader market. Comparatively, Spruce Biosciences has a beta of 3.12, indicating that its share price is 212% more volatile than the broader market.

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 91.7% of Spruce Biosciences shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 4.3% of Spruce Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Spruce Biosciences had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Spruce Biosciences and 2 mentions for Greenland Mines Ltd. Common Stock. Spruce Biosciences' average media sentiment score of 0.96 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that Spruce Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spruce Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Spruce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Spruce Biosciences	N/A	-155.40%	-101.67%

Summary

Greenland Mines Ltd. Common Stock and Spruce Biosciences tied by winning 7 of the 14 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Connect Biopharma?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Connect Biopharma (NASDAQ:CNTB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Greenland Mines Ltd. Common Stock has a beta of 6.94, indicating that its share price is 594% more volatile than the broader market. Comparatively, Connect Biopharma has a beta of -0.22, indicating that its share price is 122% less volatile than the broader market.

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Connect Biopharma. Connect Biopharma is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Connect Biopharma	$60K	2,224.59	-$55.48M	-$1.15	N/A

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 58.7% of Connect Biopharma shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 22.6% of Connect Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Greenland Mines Ltd. Common Stock had 1 more articles in the media than Connect Biopharma. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 1 mentions for Connect Biopharma. Connect Biopharma's average media sentiment score of 1.89 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that Connect Biopharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Greenland Mines Ltd. Common Stock	Positive
Connect Biopharma	Very Positive

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Connect Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Connect Biopharma	N/A	-122.29%	-97.07%

Connect Biopharma has a consensus target price of $7.20, suggesting a potential upside of 239.62%. Given Connect Biopharma's stronger consensus rating and higher probable upside, analysts clearly believe Connect Biopharma is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Connect Biopharma	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Summary

Connect Biopharma beats Greenland Mines Ltd. Common Stock on 9 of the 15 factors compared between the two stocks.

Get Greenland Mines Ltd. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRML vs. The Competition

Export

Metric	Greenland Mines Ltd. Common Stock	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$35.52M	$2.99B	$6.52B	$12.05B
Dividend Yield	N/A	1.76%	2.67%	5.66%
P/E Ratio	-0.92	18.84	24.00	24.42
Price / Sales	N/A	326.45	515.84	118.72
Price / Cash	N/A	55.88	27.48	37.92
Price / Book	2.25	3.98	10.60	6.82
Net Income	-$10.55M	$75.79M	$3.57B	$337.56M
7 Day Performance	-5.48%	1.57%	0.59%	1.16%
1 Month Performance	-23.96%	-0.73%	1.54%	3.16%
1 Year Performance	-81.69%	23.44%	25.41%	30.60%

Greenland Mines Ltd. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRML Greenland Mines Ltd. Common Stock	0.4086 of 5 stars	$0.29 flat	N/A	-81.7%	$35.52M	N/A	N/A	5	Gap Up
ADCT ADC Therapeutics	2.3385 of 5 stars	$1.10 -0.5%	$6.25 +470.8%	-70.8%	$141.31M	$81.36M	N/A	310
CNTX Context Therapeutics	3.1597 of 5 stars	$1.49 -2.3%	$6.60 +344.4%	+120.8%	$136.44M	N/A	N/A	7
NRXP NRx Pharmaceuticals	2.9809 of 5 stars	$3.76 -2.8%	$38.25 +916.5%	+11.6%	$136.41M	$1.23M	N/A	2	Positive News Analyst Upgrade
SPRB Spruce Biosciences	2.5943 of 5 stars	$48.50 -1.1%	$169.67 +249.9%	+826.2%	$133.39M	$4.91M	N/A	20	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GRML) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. ADCT, CNTX, NRXP, SPRB, and CNTB

How does Greenland Mines Ltd. Common Stock compare to ADC Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Context Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to NRx Pharmaceuticals?

Summary

How does Greenland Mines Ltd. Common Stock compare to Spruce Biosciences?

Summary

How does Greenland Mines Ltd. Common Stock compare to Connect Biopharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. ADCT, CNTX, NRXP, SPRB, and CNTB

How does Greenland Mines Ltd. Common Stock compare to ADC Therapeutics?

Which has more risk & volatility, ADCT or GRML?

Do analysts recommend ADCT or GRML?

Is ADCT or GRML more profitable?

Does the media prefer ADCT or GRML?

Do institutionals & insiders have more ownership in ADCT or GRML?

Which has stronger earnings & valuation, ADCT or GRML?

Summary

How does Greenland Mines Ltd. Common Stock compare to Context Therapeutics?

Which has more risk & volatility, CNTX or GRML?

Do analysts recommend CNTX or GRML?

Is CNTX or GRML more profitable?

Does the media prefer CNTX or GRML?

Do institutionals & insiders have more ownership in CNTX or GRML?

Which has stronger earnings & valuation, CNTX or GRML?

Summary

How does Greenland Mines Ltd. Common Stock compare to NRx Pharmaceuticals?

Does the media refer more to GRML or NRXP?

Is GRML or NRXP more profitable?

Do analysts rate GRML or NRXP?

Do insiders and institutionals have more ownership in GRML or NRXP?

Which has preferable valuation & earnings, GRML or NRXP?

Which has more volatility & risk, GRML or NRXP?

Summary

How does Greenland Mines Ltd. Common Stock compare to Spruce Biosciences?

Do analysts rate GRML or SPRB?

Which has stronger valuation and earnings, GRML or SPRB?

Which has more risk and volatility, GRML or SPRB?

Do insiders and institutionals believe in GRML or SPRB?

Does the media refer more to GRML or SPRB?

Is GRML or SPRB more profitable?

Summary

How does Greenland Mines Ltd. Common Stock compare to Connect Biopharma?

Which has more risk and volatility, GRML or CNTB?

Which has stronger valuation and earnings, GRML or CNTB?

Do insiders and institutionals believe in GRML or CNTB?

Does the media refer more to GRML or CNTB?

Is GRML or CNTB more profitable?

Do analysts rate GRML or CNTB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools